Lincoln Pharmaceuticals consolidated net profit rises 24.51% in the June 2024 quarter

Net profit of Lincoln Pharmaceuticals rose 24.51% to Rs 23.67 crore in the quarter ended June 2024 as against Rs 19.01 crore during the previous quarter ended June 2023. Sales rose 8.60% to Rs 147.28 crore in the quarter ended June 2024 as against Rs 135.62 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	147.28	135.62	9
OPM %	15.43	15.28	-
PBDT	32.70	27.99	17
PBT	29.48	25.45	16
NP	23.67	19.01	25